Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/17/1994 | EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
11/17/1994 | EP0624156A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
11/17/1994 | EP0624094A1 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents |
11/17/1994 | EP0624088A1 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
11/16/1994 | CN1095072A Difluoro pentapeptide derivative anti-inflammatory agents |
11/16/1994 | CN1095062A Preparation of pure enantiomorisomer |
11/16/1994 | CN1094950A Compositions of L-dopa esters |
11/15/1994 | US5364943 Preparation of substituted piperidines |
11/15/1994 | US5364866 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
11/15/1994 | US5364864 Enzyme inhibitors |
11/15/1994 | US5364857 Cerebral antiischaemic agents, chroman and fluorophenyl compound |
11/15/1994 | US5364856 Modification of serotonin function |
11/15/1994 | US5364854 Nervous system and gastrointestinal disorders; antiemetic, anxiolytic, and analgesic agents; cognition activators; drug abuse |
11/15/1994 | US5364845 Glucosamine, chondroitin and manganese composition for the protection and repair of connective tissue |
11/15/1994 | CA1333067C Ring substituted isoquinolines |
11/15/1994 | CA1333052C Apparatus for the controlled delivery of nicotine, process for the production thereof and the use thereof |
11/15/1994 | CA1333051C Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method |
11/11/1994 | CA2122885A1 Process for the preparation of 2-{4-¬4-(4-chloro-1-pyrazolyl) butyl|-1-piperazinyl}pyrimidine (lesopitron) |
11/10/1994 | WO1994025472A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
11/10/1994 | WO1994025470A1 Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs |
11/10/1994 | WO1994025469A1 Quinoxalindione derivatives, their preparation and their use in drugs |
11/10/1994 | WO1994025460A1 Risperidone pamoate |
11/10/1994 | WO1994025456A1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/10/1994 | WO1994025454A1 Agent acting on the central nervous system, method for its preparation and pharmaceutical compositions containing such agent |
11/10/1994 | WO1994025445A1 1,5-benzodiazepines useful as gastrin or cck-antagonists |
11/10/1994 | WO1994025444A1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists |
11/10/1994 | WO1994025427A1 Ethanolamine derivatives useful for the treatment of gastrointestinal disorders |
11/10/1994 | WO1994025073A1 Recombinant viruses and their use in gene therapy |
11/10/1994 | WO1994025029A2 Use of sabeluzole in chronic neurodegenerative diseases |
11/10/1994 | WO1994025027A1 Btp receptor modulator of the gabaa/chloride channel complex for prolonging the duration of the gaba induced membrane current |
11/10/1994 | WO1994025023A1 Use of indole derivatives as 5ht1 antagonists |
11/10/1994 | WO1994025017A1 PERNASAL PREPARATION COMPRISING threo-3-(3,4-DIHYDROXYPHENYL)SERINE |
11/10/1994 | WO1994025016A1 Novel medical use for gaba agonists |
11/10/1994 | WO1994025007A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
11/10/1994 | WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use |
11/10/1994 | CA2161679A1 Recombinant virus and their use in genic therapy |
11/10/1994 | CA2161427A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
11/10/1994 | CA2161426A1 Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs |
11/10/1994 | CA2161425A1 Quinoxalindione derivatives, their preparation and their use in drugs |
11/10/1994 | CA2160365A1 Use of sabeluzole in chronic neurodegenerative diseases |
11/10/1994 | CA2159990A1 2-,3-,4-,5-,6-,7-,8-,9-and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/10/1994 | CA2139224A1 Agent acting on the central nervous system, method for its preparation and pharmaceutical compositions containing such agent |
11/09/1994 | EP0623627A1 Sulfonamide derivatives |
11/09/1994 | EP0623620A1 5-HT3 Pyrrolopyrazine derivatives |
11/09/1994 | EP0623618A2 Pyrrolo-pyridine derivatives |
11/09/1994 | EP0623616A1 Heterocyclic compounds and process for the preparation thereof |
11/09/1994 | EP0623610A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines as Angiotensine II antagonists |
11/09/1994 | EP0623603A1 Styrene derivative and salts thereof |
11/09/1994 | EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors |
11/09/1994 | EP0623146A1 COMPOUNDS AND METHODS FOR INHIBITING $g(b)-PROTEIN FUNCTION |
11/09/1994 | EP0623132A1 Disubstituted polycyclic systems as cognition enhancers |
11/09/1994 | EP0623128A1 Indole derivatives |
11/09/1994 | EP0623118A1 Carbamate derivatives and their use in medicine |
11/09/1994 | EP0623114A1 Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
11/09/1994 | EP0623111A1 Nitroquinolone derivatives as nmda antagonists |
11/09/1994 | EP0533824B1 Piperidyl-substituted indoles |
11/09/1994 | EP0532527B1 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them |
11/09/1994 | EP0413771B1 Composition for the treatment of schizophrenia |
11/09/1994 | CN1094727A 5-arylindole derivatives |
11/09/1994 | CN1094724A 6-heterocyclic-4-amino1,3,4,5-tetrahydrobenzÛCDÙindoles for treating motion sickness and vomiting |
11/09/1994 | CN1094722A Novel treatment |
11/09/1994 | CN1094615A Compositions and method for providing improved analgesic effect |
11/09/1994 | CN1094613A Novel treatment |
11/08/1994 | US5362915 Inhibitors of enzymes/hydrolases; antiallergens, antiinflammatory agents |
11/08/1994 | US5362860 Neutral stabilization complex for CI-979 HCl, a cognition activator |
11/08/1994 | US5362740 Dihydrobenzofuran carboxamides and process for their preparation |
11/08/1994 | US5362739 Acetylcholine activators, dementia treatment |
11/08/1994 | US5362738 Used to treat muscle tension, stress, insomnia, anxiety or convulsions |
11/08/1994 | US5362735 Fungicides, immunosuppresants, antitumor agents |
11/08/1994 | US5362734 Certain benzo-quinolizine compounds and derivatives thereof |
11/08/1994 | US5362728 4,5-bridged-2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols and derivatives and compositions and methods employing such compounds |
11/08/1994 | US5362499 Burned abalone shells and sesame powder |
11/08/1994 | CA2029065C Method of treating anxiety related disorders using sertraline |
11/08/1994 | CA2024181C Method of treating chemical dependencies using sertraline |
11/08/1994 | CA2011428C Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants |
11/07/1994 | CA2122789A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
11/05/1994 | CA2122889A1 Heterocyclic compounds |
11/02/1994 | EP0622079A2 Gelatinase A for the treatment of Alzheimer's disease |
11/02/1994 | EP0621781A1 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses |
11/02/1994 | CN1094406A 3,3'-disubstituted-1,3-dihydro-2h-pyrroloÛ2,3-bÙheterocyclic-2-one useful in the treatment of cognitive disorders of man |
11/02/1994 | CN1094403A 4-heterocyclyl-substituted dihydropyridines |
11/01/1994 | US5360820 Medical use for tachykinin antagonists |
11/01/1994 | US5360809 Imidazole compounds and their use as calcium channel blockers |
11/01/1994 | US5360805 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
11/01/1994 | US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells |
11/01/1994 | US5360610 Method for stimulating nerve fiber growth |
11/01/1994 | CA2070685C Method for treating painful, inflammatory or allergic disorders |
11/01/1994 | CA1332837C 5- or 6-substituted .beta.-carboline-3-carboxylic acid esters |
11/01/1994 | CA1332836C 3-oxadiazole and 3-carboxylic acid .beta.-carboline derivatives, their production and their use as drugs |
11/01/1994 | CA1332808C Polyester-based composition for the controlled release of medicinal substances |
10/31/1994 | CA2122290A1 Pyrrolopyrazinic compounds, methods for their preparation and pharmaceutical compositions containing them |
10/30/1994 | CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors |
10/27/1994 | WO1994024151A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
10/27/1994 | WO1994024132A1 Tetrahydro-pyrido-indole |
10/27/1994 | WO1994024131A1 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders |
10/27/1994 | WO1994024129A1 Phenylpyrrole derivatives and their use as antipsychotic agents |
10/27/1994 | WO1994024127A1 Indole derivatives as 5-h1-like agonists for use in migraine |
10/27/1994 | WO1994024125A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
10/27/1994 | WO1994024116A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases |
10/27/1994 | WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease |